BioNTech SE (BNTX)
100.81
-0.80
(-0.79%)
USD |
NASDAQ |
Sep 01, 12:02
BioNTech Cash from Operations (TTM) : 725.62M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 725.62M |
| March 31, 2026 | 845.73M |
| December 31, 2025 | 516.61M |
| September 30, 2025 | -336.13M |
| June 30, 2025 | -1.878B |
| March 31, 2025 | -251.40M |
| December 31, 2024 | 225.87M |
| September 30, 2024 | 1.578B |
| June 30, 2024 | 3.164B |
| March 31, 2024 | 6.151B |
| December 31, 2023 | 5.769B |
| September 30, 2023 | 5.507B |
| Date | Value |
|---|---|
| June 30, 2023 | 9.452B |
| March 31, 2023 | 8.891B |
| December 31, 2022 | 14.16B |
| September 30, 2022 | 13.32B |
| June 30, 2022 | 10.28B |
| March 31, 2022 | 5.971B |
| December 31, 2021 | 1.053B |
| September 30, 2021 | 1.582B |
| June 30, 2021 | -434.09M |
| March 31, 2021 | -330.14M |
| December 31, 2020 | -15.43M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Biodexa Pharmaceuticals Plc | -7.385M |
| NuCana Plc | -6.332M |
| Mereo BioPharma Group Plc | -25.28M |
| MediGene AG | -- |